Home > Press > Nanomix Receives Patent for Sensation Detection Technology
Abstract:
Devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules
Nanomix Incorporated, a leading nanotechnology company commercializing nanoelectronic detection devices for industrial and biomedical applications, announced today the issuance of a U.S. patent for its nanostructured detection platform known as Sensation.
The patent includes broad claims related to nanostructured detection devices. These devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules. The devices have extremely low power requirements and are scalable for mass production in a variety of product applications.
"We are pleased with our emerging patent portfolio related to nanoelectronic detection, which supports our primary business focus," said David Macdonald, President and CEO of Nanomix. "These advancements open up a wide range of applications and commercial opportunities. As the first company to bring a nanoelectronic product to market, we are excited to be at the leading edge of this promising industry. In addition to our own products, we are currently pursuing a number of collaborations for the commercial deployment of Sensation technology."
This patent (US Patent No. 6,894,359, issued May 17, 2005) is the first to be issued in Nanomix' growing portfolio of pending patent applications for the Sensation detection platform and its industrial and biomedical uses. This follows the issuance of three previous patents related to Nanomix' hydrogen storage technology.
About Nanomix:
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistry and silicon. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanotechnology - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Sensors
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |